Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cramer

Showing results (431-440 of 449) with videos related to

Pageof 45
Sort By:
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitorsSunny Abraham, Michael J Hadd, Lan Tran, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
Applied and Environmental Microbiology|July 31, 2016
Transmission of Staphylococcus aureus from Humans to Green Monkeys in The Gambia as Revealed by Whole-Genome SequencingMadikay Senghore, Sion C Bayliss, Brenda A Kwambana-Adams, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 6, 2021
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive SummarySamantha Anne, James Whit Mims, David E Tunkel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 6, 2021
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology OperationsSamantha Anne, James Whit Mims, David E Tunkel, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitorsMark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Molecular Cancer Therapeutics|February 10, 2012
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activityJoyce James, Bruce Ruggeri, Robert C Armstrong, et al.
Human Molecular Genetics|January 21, 2009
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskBao-Li Chang, Scott D Cramer, Fredrik Wiklund, et al.
Pageof 45

Showing results (431-440 of 449) with videos related to

Sort By:
Pageof 45
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitorsSunny Abraham, Michael J Hadd, Lan Tran, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
Applied and Environmental Microbiology|July 31, 2016
Transmission of Staphylococcus aureus from Humans to Green Monkeys in The Gambia as Revealed by Whole-Genome SequencingMadikay Senghore, Sion C Bayliss, Brenda A Kwambana-Adams, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 6, 2021
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive SummarySamantha Anne, James Whit Mims, David E Tunkel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 6, 2021
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology OperationsSamantha Anne, James Whit Mims, David E Tunkel, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitorsMark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Molecular Cancer Therapeutics|February 10, 2012
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activityJoyce James, Bruce Ruggeri, Robert C Armstrong, et al.
Human Molecular Genetics|January 21, 2009
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskBao-Li Chang, Scott D Cramer, Fredrik Wiklund, et al.
Pageof 45